A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
Luis Paz-Ares, Beatrix Bálint, Richard H. de Boer, Jan P. van Meerbeeck, Rafal Wierzbicki, Paul De Souza, Francesco Galimi, Vincent Haddad, Tony Sabin, Yong-jiang Hei, Yang Pan, Susan Cottrell
(+2 others)
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Luis Paz-Ares, Beatrix Bálint, Richard H. de Boer, Jan P. van Meerbeeck, Rafal Wierzbicki, Paul De Souza, Francesco Galimi, Vincent Haddad, Tony Sabin, Yong-jiang Hei, Yang Pan, Susan Cottrell, Cheng-Pang Hsu, Rodryg RamLau. "A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer." Journal of Thoracic Oncology 8.3 (2013) 329-337